Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Drops By 24.6%

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 414,600 shares, a decline of 24.6% from the June 30th total of 549,600 shares. Based on an average trading volume of 8,100 shares, the days-to-cover ratio is presently 51.2 days.

Ascentage Pharma Group International Price Performance

Shares of Ascentage Pharma Group International stock remained flat at $2.69 on Friday. Ascentage Pharma Group International has a 1 year low of $2.35 and a 1 year high of $3.63. The company’s 50-day simple moving average is $2.69 and its 200-day simple moving average is $2.71.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.